# Dovato

NDC: 49702-246
Generic name: dolutegravir sodium and lamivudine
Labeler / Manufacturer: ViiV Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190408

FDA application: NDA211994

## Active ingredients

- DOLUTEGRAVIR SODIUM: 50 mg/1
- LAMIVUDINE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49702-246"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49702-246
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68e45422-43ed-4cfb-9356-fae88d14a53a